Dexcom (DXCM) Assets (2010 - 2026)

Dexcom (DXCM) has 17 years of Assets data on file, last reported at $6.6 billion in Q1 2026.

• On a quarterly basis, Assets fell 1.75% year-over-year to $6.6 billion in Q1 2026; TTM through Mar 2026 was $6.6 billion, a 1.75% decrease from a year earlier, with the FY2025 full-year figure at $6.3 billion, down 2.23% from the prior year.
• Assets for Q1 2026 stood at $6.6 billion, up from $6.3 billion in the prior quarter.
• Over the last five years, Assets for DXCM reached as high as $7.5 billion in Q3 2025 and fell as low as $4.9 billion in Q3 2022.
• Historically, Assets has averaged $6.3 billion across 5 years, with a median of $6.5 billion in 2024.
• Across the five-year window, Assets soared 34.64% in 2023 and decreased 3.67% in 2024, its largest moves.
• Year by year, Assets stood at $5.4 billion in 2022, then advanced by 16.19% to $6.3 billion in 2023, then advanced by 3.51% to $6.5 billion in 2024, then fell by 2.23% to $6.3 billion in 2025, then gained by 4.63% to $6.6 billion in 2026.
• Per Business Quant data, the three most recent Assets figures were $6.6 billion in Q1 2026, $6.3 billion in Q4 2025, and $7.5 billion in Q3 2025.